ArticleNature communications2023

Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial.

Arta M Monjazeb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.